Gesundheit Nord gGmbH Klinikverbund Bremen — Clinical Trial Site

62 Registered trials

34 Currently recruiting

Organisation

Gesundheit Nord gGmbH Klinikverbund Bremen

Location

Bremen, Germany

Identifier

ORG-100041768

Address

Zuericher Strasse 40, Ellenerbrok-Schevemoor, 28325, Germany

Departments

#2050:Medizinische Klinik I
Clinic for Pneumology and Respiratory medicine
Department of Dermatology
Department of Gastroenterology, Hepatology, Endocrinology and Nutrition
Department of Gynecology and Obstetrics
Department of Medical Clinic I
Dermatology and allergology
Eltern-Kind-Zentrum Prof. Hess
Eltern-Kind-Zentrum Prof. Hess Kinderonkologie
Eltern-Kind-Zentrum Prof. Hess, Kinderonkologie
Gastroenterology, Hepatology, Endocrinology & nutrition
Hematology/Oncology
Innere Medizin
Kinderonkologisches Zentrum
Kinderonkologisches Zentrum-Station 3
Kinderonkologisches Zentrum-Station 3, Haus 4, Ebene 2
Klinik für Dermatologie, Dermatochirurgie, Dermatoonkologie und Allergologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Gynäkologie und Senologie
Klinik für Gynäkologie, Gynäkoonkologie und Senologie
Klinik für Innere Medizin I
Klinik für Innere Medizin II
Klinik für Kinder- und Jugendhämatologie und -Onkologie
Klinik für Neurologie
Klinik fur Pneumologie und Beatmungsmedizin
Klinikum Bremen Mitte, Fachärztezentrum Hanse GmbH, FB Strahlentherapie
Klinikum Bremen Mitte, Innere Medizin I
Klinikum Bremen Ost
Klinikum Bremen-Mitte
Klinikum Bremen-Mitte, Eltern-Kind-Zentrum Prof. Hess, Kinderonkologie-Station 3
Klinikum Bremen-Ost
Med. Klinik I
Medical Clinic II
Medizinische Klinik 1
Medizinische Klinik I
Medizinische Klinik I Klinikum Bremen-Mitte
Medizinische Klinik I, Abt. Haematologie/Onkologie
Medizinische Klinik II
Medzinische Klinik I
N/A
Neurologische Klinik
Pädiatrische Hämatologie und Onkologie
Paediatric Oncology
Paedriatrics, Department of Oncology and Hematology
pediatric hematologie/Oncology
Pediatric hematology and oncology
Private Practice
Senology und gynäkologische systematische Therapie

Clinical trials at this site (62)

Search interface

A multicenter, single-arm phase II study to assess the safety, tolerability, and efficacy of Isatuximab in adult patients with cytologic or … Recruiting

2023-507899-47-00 Cytologic or molecular relapsed/refractory CD38 positiv 4 2024-10-22
A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chron… Recruiting

2023-508338-33-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2024-10-01
A trial to evaluate the efficacy and safety of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) in patients with mild to moderate… Recruiting

2024-510807-13-00 ulcerative colitis 10 2024-09-12
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting

2023-505436-35-00 Untreated FLIPI 2-5 Follicular Lymphoma 5 2024-06-03
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line tr… Recruiting

2024-512320-11-00 Primary diffuse large B-cell lymphoma of the central ne 5 2023-08-09
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::AB 4 2023-07-13
A Randomized, Placebo‐Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Di… Recruiting

2023-507518-28-00 Acute myeloid leukemia 5 2022-09-13
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA) Recruiting

2024-512701-11-00 Systemic Juvenile Idiopathic Arthritis (sJIA) 4 2018-08-29
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
Frontline Asciminib combination in chronic phase CML Ended

2024-516212-24-00 Chronic Myeloid Leukemia 4 2024-10-08
Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma Ended

2022-500571-32-00 Early-Stage Unfavorable Classical Hodgkin Lymphoma 4 2024-05-15
A study to evaluate the safety and long-term biomarker effects of RO7269162 in participants at risk for or at the prodromal stage of Alzheim… Ended

2023-506183-13-00 Alzheimer’s Disease 4 2024-03-29
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With N… Ended

2024-510947-71-00 Chronic Myeloid Leukemia 5 2022-11-21
A study in patients with skin cancer Ended

2024-516914-39-00 Metastatic or unresectable melanoma 5 2022-04-27
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and … Ended

2024-514473-21-00 Primary diffuse large B-cell lymphoma (DLBCL) of the ce 5 2021-06-21
The TARGET BP I Ended

2024-512525-83-00 Hypertension 5 2020-01-07
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28